Omnicell Inc reports results for the quarter ended in September - Earnings Summary

Omnicell

02/11/2023 13:33

* Omnicell Inc  OMCL.OQ  reported quarterly adjusted
earnings of
62 cents​​ per share for the quarter ended in September, lower
than the same quarter last year, when the company reported EPS
of $1.00.  The mean expectation of eight analysts for the
quarter was for earnings of 47 cents per share. Wall Street
expected results to range from 42 cents to 49 cents per share.
    * Revenue fell 14.2% to $298.66 million from a year ago;
analysts
expected $295.47 million. 
    * Omnicell Inc's reported EPS for the quarter was 12 cents​.
    * The company reported quarterly net income of $5.55
million.
    * Omnicell Inc shares had fallen by 20.6% this quarter and
lost 29.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.7%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Omnicell Inc is
$70.00 
This summary was machine generated from LSEG data November 2 at
01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      0.47           0.62           Beat
 Jun. 30 2023      0.28           0.57           Beat
 Mar. 31 2023      0.07           0.39           Beat
 Dec. 31 2022      0.09           0.33           Beat